Immix Biopharma Shares Drop After Termination of Chief Medical Officer
Shares of Immix Biopharma (IMMX) fell approximately 14% following the announcement that its Chief Medical Officer, Richard Graydon, was terminated. The company stated his departure is unrelated to his work and emphasized it should not have a material impact due to his short tenure.
Tickers: $IMMX
Topics: executive departure management change